Inorganic cofactors include the following EXCEPT:
A. Ca2+
B. Mn2+
C. Zn2+
D. PO4 2-
D. PO4 2-
A CK assay using Oliver–Rosalki method gives an error flag indicating substrate depletion. The sample is diluted 1:2 and 1:4 and reassayed. After correcting for the dilution, the results are as follows: 1:2 dilution = 3,000 IU/L; 1:4 dilution = 3,600 IU/L. What is the most likely explanation?
A. The serum became contaminated prior to making the 1:4 dilution
B. The wrong pipet was used to make one of the dilutions
C. An endogenous competitive inhibitor is present in the sample
D. An error has been made in calculating the enzyme activity of one of the two dilutions
C. An endogenous competitive inhibitor is present in the sample
Which of the following types of inhibitors binds to allosteric sites causing a change in the enzyme’s conformation?
A. Competitive
B. Non-competitive
C. Uncompetitive
D. None of these
B. Non-competitive
Increasing the substrate concentration will increase ______ inhibition.
A. Competitive
B. Noncompetitive
C. Uncompetitive
D. End product
A. Competitive
Enzymes with macroforms include the following EXCEPT:
A. Amylase
B. CK
C. GGT
D. G6PD
D. G6PD
Which AMI marker becomes abnormal 4-6 hours postinfarction, peaks in 12–24 hours, and usually returns to normal within 2-3 days?
A. Troponin
B. AST
C. CK-MB
D. Myoglobin
C. CK-MB
Which of the following is the most abundant CK isoenzyme found in striated muscle and normal serum?
A. CK1
B. CK2
C. CK3
D. Macro-CK
C. CK3 (CK - MM)
A slow cathodic peak and an intermediate peak in CK isoenzyme fractionation are consistent with
A. Muscular dystrophy
B. Viral hepatitis
C. Brain tumor
D. Myocardial infarction
D. Myocardial infarction
Which is the most labile CK isoenzyme?
A. CK-BB
B. CK-MB
C. CK-MM
D. CK-Mi
A. CK-BB (CK-1)
The following are characterized by pronounced CK elevation EXCEPT:
A. Duchenne’s muscular dystrophy
B. Polymyositis
C. Myocardial infarction
D. Pulmonary infarction
D. Pulmonary infarction
Calculate the anion gap given the following information: glucose – 124 mg/dL; BUN – 22 mg/dL;
sodium – 138 mmol/L; potassium – 5 mmol/L; chloride – 105 mmol/L; bicarbonate – 25 mmol/L.
A. 13 mmol/L
B. 13 mOsm/kg
C. 290 mOsm/kg
D. 290 mmol/L
A. 13 mmol/L
Low anion gap may be caused by:
A. Decreased unmeasured cations and increased unmeasured anions
B. Increased unmeasured cations and anions
C. Increased unmeasured cations and decreased unmeasured anions
D. Decreased unmeasured cations and anions
C. Increased unmeasured cations and decreased unmeasured anions
The denominator in the Henderson-Hasselbalch equation represents the function of the:
A. Kidneys
B. Lungs
C. Blood
D. Heart
B. Lungs
Which of the following correctly describes the composition of a buffer solution?
A. Weak acid and its conjugate base
B. Strong acid and its conjugate base
C. Strong base and its conjugate acid
D. Weak base and its salt
A. Weak acid and its conjugate base
Which of the following correctly describes a base?
A. Yields hydrogen ions when dissolved in water
B. Donates proton in a reaction
C. Accepts a pair of electrons to form a covalent bond
D. Gives off hydroxyl ions in solution
D. Gives off hydroxyl ions in solution
Increased anion gaps can result from:
1. Lactic acidosis
2. Uremia
3. Salicylate toxicity
4. Hyponatremia
A. 1 and 3
B. 2 and 4
C. 1, 2, and 3
D. 1, 2, 3, and 4
C. 1, 2, and 3
Which of the following represents the metabolic component of acid-base status?
A. Carbonic acid
B. Bicarbonate
C. Hydrogen
D. Carbon dioxide
B. Bicarbonate
The following are associated with decreased anion gap EXCEPT:
A. Hypoalbuminemia
B. Multiple myeloma
C. Hypercalcemia
D. Ethylene glycol poisoning
D. Ethylene glycol poisoning
Which of the following represents the Henderson-Hasselbalch equation as applied to blood pH?
A. 6.1 + log HCO3
–/(0.03 x PCO2)
B. 6.1 + log HCO3
–/PCO2
C. 6.1 + log DCO2/HCO3
D. 6.1 + log (0.03 x PCO2)/HCO3
–
A. 6.1 + log HCO3
–/(0.03 x PCO2)
The pressure of dissolved CO2 (pCO2) represents the concentration of:
A. Hydrogen ions
B. Dissolved oxygen
C. Carbonic acid
D. Bicarbonate
C. Carbonic acid
The term pharmacodynamics is an expression of the relationship between:
A. Dose and physiological effect
B. Drug concentration at target sites and physiological effect
C. Time and serum drug concentration
D. Blood and tissue drug levels
B. Drug concentration at target sites and physiological effect
Which of the following statements best describes the TD50 of a compound?
A. The dosage of a substance that would be predicted to cause a toxic effect in 50% of the population
B. The dosage of a substance that would produce therapeutic benefit in 50% of the population
C. The percentage of individuals who would experience a toxic response at 50% of the lethal dose
D. The percentage of the population who would experience a toxic response after an oral dosage of 50 mg
A. The dosage of a substance that would be predicted to cause a toxic effect in 50% of the population
Select the pharmacological parameters that determine plasma drug concentration.
A. Absorption, anabolism, bioactivation, excretion
B. Equilibration, biotransformation, reabsorption, elimination
C. Absorption, distribution, metabolism, excretion
D. Ingestion, assimilation, metabolism, elimination
C. Absorption, distribution, metabolism, excretion
The phrase “first-pass metabolism” means that:
A. One hundred percent of a drug is excreted by the liver
B. All drug is inactivated by hepatic enzymes after passing through the liver
C. Some drugs are metabolized from the portal circulation, reducing bioavailability
D. The drug must be converted in the liver to an active form
C. Some drugs are metabolized from the portal circulation, reducing bioavailability